← Scroll for more →
Financial Statements — KRSA
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.39 | 2.82 | 3.24 | 4.57 | 3.01 | 3.64 | 3.23 | 2.87 | 4.59 | 5.70 | 7.57 | 9.11 | 5.64 | 7.17 | 13.38 | 20.41 | 30.32 | 41.13 | 53.96 | 62.50 |
| Accounts Receivable | 0.00 | 0.00 | 1.00 | 0.10 | 0.53 | 0.58 | 0.56 | 0.04 | -- | -- | 0.00 | 0.00 | 0.00 | 0.10 | 0.10 | 0.23 | 0.23 | 0.23 | 0.10 | 0.16 |
| Total Current Assets | 1.51 | 3.09 | 4.64 | 5.07 | 4.02 | 4.50 | 4.22 | 3.55 | 4.72 | 6.01 | 8.02 | 9.86 | 7.11 | 8.34 | 14.82 | 21.66 | 31.68 | 42.84 | 55.46 | 63.68 |
| Property, Plant & Equipment | 0.07 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.07 | 0.11 |
| Total Non-current Assets* | 5.42 | 5.42 | 5.35 | 5.35 | 5.35 | 5.35 | 5.35 | 5.35 | 5.35 | 5.35 | 5.35 | 5.35 | 2.98 | 3.12 | 3.26 | 3.40 | 3.53 | 3.69 | 3.87 | 4.06 |
| Total Assets | 6.93 | 8.51 | 9.99 | 10.42 | 9.37 | 9.85 | 9.57 | 8.90 | 10.07 | 11.36 | 13.37 | 15.21 | 10.10 | 11.46 | 18.08 | 25.05 | 35.21 | 46.53 | 59.33 | 67.74 |
| Accounts Payable | 1.60 | 0.46 | 0.51 | 0.48 | 0.46 | 0.48 | 0.39 | 0.30 | 0.65 | 0.74 | 1.20 | 0.81 | 1.86 | 3.93 | 2.97 | 1.65 | 2.77 | 2.52 | 1.83 | 1.17 |
| Short-term Debt | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.50 | -- | -- | -- | 3.50 | -- |
| Total Current Liabilities | 1.84 | 1.71 | 0.90 | 0.88 | 0.80 | 1.07 | 0.73 | 0.70 | 1.28 | 1.44 | 2.09 | 2.34 | 4.95 | 7.53 | 7.63 | 8.53 | 9.85 | 9.49 | 11.09 | 11.36 |
| Total Non-current Liabilities* | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities* | 1.84 | 1.71 | 0.90 | 0.88 | 0.80 | 1.07 | 0.73 | 0.70 | 1.28 | 1.44 | 2.09 | 2.34 | 4.95 | 7.53 | 7.63 | 8.53 | 9.85 | 9.49 | 11.09 | 11.36 |
| Retained Earnings | (275.95) | (274.20) | (271.02) | (270.22) | (269.24) | (268.92) | (267.49) | (268.02) | (267.30) | (265.96) | (264.42) | (262.72) | (270.29) | (266.11) | (259.15) | (251.94) | (241.44) | (228.05) | (215.08) | (204.30) |
| Total Stockholder Equity | 5.09 | 6.79 | 9.09 | 9.54 | 8.57 | 8.78 | 8.85 | 8.20 | 8.78 | 9.92 | 11.29 | 12.87 | 5.15 | 3.93 | 10.45 | 16.52 | 25.36 | 37.03 | 48.25 | 56.39 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 1.02 | 0.88 | 0.09 | 0.08 | 1.81 | 0.19 | -- | -- | 0.00 | 0.00 | 0.00 | 0.00 | 0.61 | 0.00 | 0.31 | 0.71 | 0.53 | 0.35 |
| Research & Development | 0.00 | 0.73 | 0.52 | 0.35 | 0.06 | 0.04 | 0.06 | 0.08 | 0.11 | 0.04 | (3.72) | 0.58 | 0.89 | 3.77 | 4.45 | 7.08 | 10.22 | 9.74 | 10.46 | 7.03 |
| Selling, General & Admin | 1.77 | 2.48 | 1.34 | 1.53 | 1.71 | 1.50 | 1.25 | 1.24 | 1.28 | 1.57 | (0.62) | 2.13 | 3.36 | 3.27 | 3.51 | 3.53 | 3.52 | 3.95 | 4.41 | 4.60 |
| Total Operating Expenses | 1.77 | 3.21 | 1.86 | 1.88 | 1.77 | 1.54 | 1.30 | 1.32 | 1.38 | 1.62 | (4.35) | 6.02 | 4.24 | 7.04 | 7.96 | 10.61 | 13.74 | 13.70 | 14.87 | 11.63 |
| Operating Income | (1.77) | (3.21) | (0.84) | (1.01) | (1.67) | (1.46) | 0.50 | (1.13) | (1.38) | (1.62) | 4.35 | (6.01) | (4.24) | (7.04) | (7.35) | (10.61) | (13.43) | (12.98) | (14.34) | (11.28) |
| Net Income | (1.75) | (3.18) | (0.80) | (0.98) | (0.32) | (1.43) | 0.53 | (0.72) | (1.32) | (1.54) | (1.69) | 7.57 | (4.18) | (6.95) | (7.22) | (10.50) | (13.39) | (12.98) | (10.78) | (11.29) |
| Basic EPS | (0.41) | (0.76) | (0.98) | (0.30) | (0.11) | (0.56) | 1.61 | (0.29) | (0.53) | (0.62) | (23.59) | 3.11 | (1.83) | (0.16) | (1.12) | (0.24) | (0.31) | -- | -- | -- |
| Diluted EPS | (0.41) | (0.76) | (0.98) | (0.30) | (0.11) | (0.56) | 1.61 | (0.29) | (0.53) | (0.62) | (20.86) | 2.72 | (1.83) | (0.16) | (1.12) | (0.24) | (0.31) | -- | -- | -- |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | (1.43) | (1.18) | (1.58) | (0.26) | (0.50) | (0.97) | 0.36 | (1.72) | (1.11) | (1.87) | (1.54) | (6.93) | (6.55) | (6.21) | (7.04) | (9.91) | (10.82) | (12.83) | (8.63) | (7.92) |
| Capital Expenditures | 0.00 | 0.07 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | 0.00 | -- | -- | 0.00 | 0.01 |
| Free Cash Flow* | (1.43) | (1.24) | -- | -- | -- | (0.97) | -- | -- | -- | -- | -- | -- | -- | -- | (7.04) | (9.91) | -- | -- | (8.63) | (7.93) |
| Investing Cash Flow | 0.00 | (0.07) | -- | -- | -- | 0.00 | 0.00 | 0.00 | 0.00 | -- | 0.00 | 10.40 | -- | -- | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.01) |
| Financing Cash Flow | 0.00 | 0.83 | 0.25 | 1.83 | (0.13) | 1.38 | 0.00 | 0.00 | 0.00 | -- | 0.00 | 0.00 | 5.02 | -- | 0.01 | 0.00 | 0.02 | 0.00 | 0.09 | 0.04 |
← Scroll for more columns →
* Derived from reported values